Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pimasertib-associated ophthalmological adverse events.
van Dijk EHC, Kruit WHJ, Jager MJ, Luyten GPM, Vingerling JR, Boon CJF. van Dijk EHC, et al. Among authors: vingerling jr. Acta Ophthalmol. 2018 Nov;96(7):712-718. doi: 10.1111/aos.13677. Epub 2018 Jan 16. Acta Ophthalmol. 2018. PMID: 29338133 Free article. Clinical Trial.
A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade(®)) in exudative age-related macular degeneration.
van Hagen PM, Baarsma GS, van Bilsen CE, Kuijpers RW, van Laar JA, van der Ent M, van Daele PL, Veeger NJ, Vingerling JR, Missotten TO. van Hagen PM, et al. Among authors: vingerling jr. Acta Ophthalmol. 2014 Dec;92(8):e691-2. doi: 10.1111/aos.12471. Epub 2014 Jun 22. Acta Ophthalmol. 2014. PMID: 24953977 Free article. Clinical Trial. No abstract available.
Axial length growth and the risk of developing myopia in European children.
Tideman JWL, Polling JR, Vingerling JR, Jaddoe VWV, Williams C, Guggenheim JA, Klaver CCW. Tideman JWL, et al. Among authors: vingerling jr. Acta Ophthalmol. 2018 May;96(3):301-309. doi: 10.1111/aos.13603. Epub 2017 Dec 19. Acta Ophthalmol. 2018. PMID: 29265742 Free PMC article.
Antiplatelet and Anticoagulant Drugs Do Not Affect Visual Outcome in Neovascular Age-Related Macular Degeneration in the BRAMD Trial.
Buitendijk GHS, Schauwvlieghe AME, Vingerling JR, Schlingemann RO, Klaver CCW; comparing Bevacizumab to Ranibizumab in Age-related macular degeneration (BRAMD) Trial Research Group. Buitendijk GHS, et al. Among authors: vingerling jr. Am J Ophthalmol. 2018 Mar;187:130-137. doi: 10.1016/j.ajo.2018.01.003. Epub 2018 Jan 9. Am J Ophthalmol. 2018. PMID: 29330064 Clinical Trial.
Antithrombotic medication and incident open-angle glaucoma.
Marcus MW, Müskens RP, Ramdas WD, Wolfs RC, de Jong PT, Vingerling JR, Hofman A, Stricker BH, Jansonius NM. Marcus MW, et al. Among authors: vingerling jr. Invest Ophthalmol Vis Sci. 2012 Jun 20;53(7):3801-5. doi: 10.1167/iovs.12-9604. Invest Ophthalmol Vis Sci. 2012. PMID: 22589449 Free article.
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial.
Vader MJC, Schauwvlieghe AME, Verbraak FD, Dijkman G, Hooymans JMM, Los LI, Zwinderman AH, Peto T, Hoyng CB, van Leeuwen R, Vingerling JR, de Jong-Hesse Y, van Lith-Verhoeven JJC, Dijkgraaf MGW, Schlingemann RO; Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) Study Group. Vader MJC, et al. Among authors: vingerling jr. Ophthalmol Retina. 2020 Jun;4(6):576-587. doi: 10.1016/j.oret.2019.12.019. Epub 2020 Jan 7. Ophthalmol Retina. 2020. PMID: 32107188 Free article. Clinical Trial.
189 results